Switching and combining dopamine agonists

Switching from one dopamine agonist to another is common practice in the treatment of patients with Parkinson's disease. This paper describes some ideas on the most practical way to perform switching. In addition, it describes the possibilities of combining various dopamine agonists and discuss...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Neural Transmission 2003-12, Vol.110 (12), p.1393-1400
Hauptverfasser:	REICHMANN, H, HERTING, B, MÜLLER, A, SOMMER, U
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiparkinson Agents - adverse effects Antiparkinson Agents - pharmacokinetics Antiparkinson Agents - therapeutic use Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dopamine Agonists - adverse effects Dopamine Agonists - pharmacokinetics Dopamine Agonists - therapeutic use Drug Therapy, Combination Fundamental and applied biological sciences. Psychology Humans Medical sciences Neurology Parkinson Disease - drug therapy Practice Patterns, Physicians Vertebrates: nervous system and sense organs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Switching from one dopamine agonist to another is common practice in the treatment of patients with Parkinson's disease. This paper describes some ideas on the most practical way to perform switching. In addition, it describes the possibilities of combining various dopamine agonists and discusses pros and cons for doing so.
ISSN:	0300-9564 1435-1463
DOI:	10.1007/s00702-003-0081-z